Performance of the sFLT-1 / PLGF Ratio in the Diagnosis of Preeclampsia in Four Hospitals in Brazzaville (Republic of Congo)

Eouani Levy Max Emery; Buambo Gauthier Regis Jostin; Mouhingou Belmar Nick-Desy; Mokoko Jules Cesar; Potokoue Mpia Sekangue Samantha Nuelly; Itoua Clautaire; Iloki Leon Herve

doi:doi:10.11648/j.jgo.20221002.20

Performance of the sFLT-1 / PLGF Ratio in the Diagnosis of Preeclampsia in Four Hospitals in Brazzaville (Republic of Congo)

Eouani Levy Max Emery, Buambo Gauthier Regis Jostin, Mouhingou Belmar Nick-Desy, Mokoko Jules Cesar, Potokoue Mpia Sekangue Samantha Nuelly, Itoua Clautaire, Iloki Leon Herve

Published in Journal of Gynecology and Obstetrics (Volume 10, Issue 2)

Received: 21 March 2022 Accepted: 7 April 2022 Published: 14 April 2022

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Preeclampsia is a serious obstetric situation, responsible for high maternal and perinatal morbidity and mortality. Its diagnosis is clinical and biological, with confirmation either by proteinuria on the urine dipstick or by 24-hour proteinuria constituting the gold standard. Current revisions to the definition of preeclampsia tend to free themselves from reliance on proteinuria for diagnosis. They are oriented towards a broader model where the involvement of a target organ concomitant with gestational hypertension is sufficient to make the diagnosis of preeclampsia. Late positivity of proteinuria after the onset of arterial hypertension (HTA) has been reported, contrasting with the precocity of angiogenic factors such as soluble Fms tyrosine kinase type 1 (sFlt-1) and placental growth factor (PlGF). Objective. To evaluate the performance of the sFLT-1/PLGF ratio in the diagnosis of preeclampsia. Methods. Cross-sectional multicenter analytical study conducted from October 17 to December 17, 2020 including hypertensive pregnant women, treated or not, with more than 20 weeks of amenorrhea. These all benefited from the Elisa assay of sFLT-1 and PlGF after carrying out the proteinuria on the urine dipstick during the consultation. Preeclampsia was defined by the double positivity of proteinuria on the urine dipstick associated with high blood pressure (Systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg). SPSS software was used for statistical analysis and calculation of performance indices (Se; Sp; PPV; NPV; Youden “J” index, AUC). The p-value of the probability was considered significant for a value < 0.05. Results. Pregnant women were mostly multiparous with a median age of 31 years (24-35). Preeclampsia was noted in 69.2% of cases. sFLT-1 was significantly higher in preeclamptic pregnant women (409±18.9 vs 194.6±12.9; p<0.05). No significant difference was noted for PlGF (11.9 vs 13.6; p< 0.05). The sFlt-1/PlGF ratio was higher in case of preeclampsia (39.3 vs 14.6; p< 0.05). The threshold for the sFlt-/PlGF ratio retained was 18.5 (Se=86.4%; Sp=84.6%; PPV=90.5%; NPV=78.6%; J = 0.7; AUC =0.9). Conclusion. The sFlt-1/PlGF ratio was effective in the diagnosis of preeclampsia.

Published in	Journal of Gynecology and Obstetrics (Volume 10, Issue 2)
DOI	10.11648/j.jgo.20221002.20
Page(s)	126-130
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2022. Published by Science Publishing Group

Keywords

Preeclampsia, sFLT-1/PLGF Ratio, Diagnostic, Brazzaville

References

[1]	Mol BWJ, Robert CT, Thangaratinam S, Magee LA, De Groot CJM, Hofmeyr GJ. Preeclampsia. Lancet Lond Engl 2015; 387: 999-1011.
[2]	Kuklina EV, Ayala C, Callaghan WM. Hypertensive Disorders and Severe Obstetric Morbidity in the United States. Obstet Gynecol 2009; 113 (6): 1299-306.
[3]	Bejjani L, Nedellec S, Taïeb J, Thervet E, Benachi A. Spot Urinary Protein to Creatinine Ratio: Which Role in Preeclampsia Diagnosis? J Gynecol Obstet Biol Reprod 2015; 44 (9): 795-801.
[4]	American College of Obstetricians, Gynecologists, Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American college of obstetricians and gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol 2013; 122 (5): 1122-31.
[5]	Sibai BM, Stella CL. Diagnosis and management of atypical preeclampsia-eclampsia. Am J Obstet Gynecol 2009; 200: 481-7.
[6]	Hagmann H, Thadhani R, Benzing T, Karumanchi SA, Stepan H. The Promise of Angiogenic Markers for the Early Diagnosis and Prediction of Preeclampsia. Clin Chem 2012; 58 (5): 837-45.
[7]	Vatten LJ, Eskild A, Nilsen TI, Jeansson S, Jenum PA, Staff AC. Changes in Circulating Level of Angiogenic Factors from the First to Second Trimester as Predictors of Preeclampsia. Am J Obstet Gynecol 2007; 196 (3): 239: 1-6.
[8]	Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennstrôm M and al. Predictive Value of the sFlt-1: PlGF Ratio in Women with Suspected Preeclampsia. N Engl J Med. 2016; 374: 13-22.
[9]	Liu Y, Zhao Y, Yu A, Zhao B, Gao Y, Niu H. "Diagnostic Accuracy of the Soluble Fms-like 640 Tyrosine Kinase-1/placental Growth Factor Ratio for Preeclampsia: a meta-analysis 641 based on 20 studies ". Arch Gynecol Obstet 2015; 292: 507-18.
[10]	Surbek D, Hodel M, Baumann M, Lapaire O. Use of the Flt-1/PlGF Test in the Diagnosis of Preeclampsia. Swiss Society of Gynecology and Obstetrics. Expert Opinion No. 67. [Cited 2019 Dec 02]. Available at: https://www.sggg.ch/fileadmin/user_upload/67_F_Diagnostik_Praeeklampsie.pdf
[11]	Vieillefosse S, Guibourdenche J, Atallah A, Haddad B, Fournier T, Tsatsaris V and al. Predictive and Prognostic Factors of Preeclampsia: Interest of PlGF and sFLT-1 Assay. J Gynecol Obstet Biol Reprod 2016; 45 (9): 999-1008.
[12]	Aksas K, Zenati A. Contribution of the Assay of sFlt-1 and PLGF Biomarkers in Screening for Preeclampsia during the First Two Trimesters of Pregnancy [Thesis]. Algiers: University of Algiers; 2019 [cited 2019 Mar 25]. Available at: http://hdl.handle.net/1635/14865.
[13]	Stepan H, Herraizb I, Schlembach D and al. Implementation of the sFlt-1/PlGF Ratio for the Prediction and Diagnosis of Preeclampsia in Singleton Pregnancy: Implication for Clinical Practice. Ultrasound Obstet Gynecol 2015; 45: 241-6.
[14]	Verbeurgt L, Chantraine F, De Marchin J, Minon J-M, Nisolle M. The Use of the sFlt-1/PlGF Ratio in Preeclampsia: A Single-Center Retrospective Analysis. Rev Med Liege 2017; 72 (9): 393-8.
[15]	Foidart JM, Schaaps JP, Chantraine F, Munaut C, Lorquet S. Dysregulation of Anti-angiogenic Agents (sFLT-1, PlGF an Endogline) in Preeclampsia-a Step Forward but not the Definitive Answer. J Reprod Immunol 2009; 82 (2): 106-11.
[16]	Verlohren S, Stepan H, Dechend R. Angiogenic Growth Factors in the Diagnosis and Prediction of Preeclampsia. Clin Sci 2012; 122 (2): 43-52.

Cite This Article

Plain Text BibTeX RIS

APA Style

Eouani Levy Max Emery, Buambo Gauthier Regis Jostin, Mouhingou Belmar Nick-Desy, Mokoko Jules Cesar, Potokoue Mpia Sekangue Samantha Nuelly, et al. (2022). Performance of the sFLT-1 / PLGF Ratio in the Diagnosis of Preeclampsia in Four Hospitals in Brazzaville (Republic of Congo). Journal of Gynecology and Obstetrics, 10(2), 126-130. https://doi.org/10.11648/j.jgo.20221002.20

Copy | Download

ACS Style

Eouani Levy Max Emery; Buambo Gauthier Regis Jostin; Mouhingou Belmar Nick-Desy; Mokoko Jules Cesar; Potokoue Mpia Sekangue Samantha Nuelly, et al. Performance of the sFLT-1 / PLGF Ratio in the Diagnosis of Preeclampsia in Four Hospitals in Brazzaville (Republic of Congo). J. Gynecol. Obstet. 2022, 10(2), 126-130. doi: 10.11648/j.jgo.20221002.20

Copy | Download

AMA Style

Eouani Levy Max Emery, Buambo Gauthier Regis Jostin, Mouhingou Belmar Nick-Desy, Mokoko Jules Cesar, Potokoue Mpia Sekangue Samantha Nuelly, et al. Performance of the sFLT-1 / PLGF Ratio in the Diagnosis of Preeclampsia in Four Hospitals in Brazzaville (Republic of Congo). J Gynecol Obstet. 2022;10(2):126-130. doi: 10.11648/j.jgo.20221002.20

Copy | Download

@article{10.11648/j.jgo.20221002.20,
  author = {Eouani Levy Max Emery and Buambo Gauthier Regis Jostin and Mouhingou Belmar Nick-Desy and Mokoko Jules Cesar and Potokoue Mpia Sekangue Samantha Nuelly and Itoua Clautaire and Iloki Leon Herve},
  title = {Performance of the sFLT-1 / PLGF Ratio in the Diagnosis of Preeclampsia in Four Hospitals in Brazzaville (Republic of Congo)},
  journal = {Journal of Gynecology and Obstetrics},
  volume = {10},
  number = {2},
  pages = {126-130},
  doi = {10.11648/j.jgo.20221002.20},
  url = {https://doi.org/10.11648/j.jgo.20221002.20},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.jgo.20221002.20},
  abstract = {Preeclampsia is a serious obstetric situation, responsible for high maternal and perinatal morbidity and mortality. Its diagnosis is clinical and biological, with confirmation either by proteinuria on the urine dipstick or by 24-hour proteinuria constituting the gold standard. Current revisions to the definition of preeclampsia tend to free themselves from reliance on proteinuria for diagnosis. They are oriented towards a broader model where the involvement of a target organ concomitant with gestational hypertension is sufficient to make the diagnosis of preeclampsia. Late positivity of proteinuria after the onset of arterial hypertension (HTA) has been reported, contrasting with the precocity of angiogenic factors such as soluble Fms tyrosine kinase type 1 (sFlt-1) and placental growth factor (PlGF). Objective. To evaluate the performance of the sFLT-1/PLGF ratio in the diagnosis of preeclampsia. Methods. Cross-sectional multicenter analytical study conducted from October 17 to December 17, 2020 including hypertensive pregnant women, treated or not, with more than 20 weeks of amenorrhea. These all benefited from the Elisa assay of sFLT-1 and PlGF after carrying out the proteinuria on the urine dipstick during the consultation. Preeclampsia was defined by the double positivity of proteinuria on the urine dipstick associated with high blood pressure (Systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg). SPSS software was used for statistical analysis and calculation of performance indices (Se; Sp; PPV; NPV; Youden “J” index, AUC). The p-value of the probability was considered significant for a value Results. Pregnant women were mostly multiparous with a median age of 31 years (24-35). Preeclampsia was noted in 69.2% of cases. sFLT-1 was significantly higher in preeclamptic pregnant women (409±18.9 vs 194.6±12.9; pConclusion. The sFlt-1/PlGF ratio was effective in the diagnosis of preeclampsia.},
 year = {2022}
}

Copy | Download

TY - JOUR
T1 - Performance of the sFLT-1 / PLGF Ratio in the Diagnosis of Preeclampsia in Four Hospitals in Brazzaville (Republic of Congo)
AU - Eouani Levy Max Emery
AU - Buambo Gauthier Regis Jostin
AU - Mouhingou Belmar Nick-Desy
AU - Mokoko Jules Cesar
AU - Potokoue Mpia Sekangue Samantha Nuelly
AU - Itoua Clautaire
AU - Iloki Leon Herve
Y1 - 2022/04/14
PY - 2022
N1 - https://doi.org/10.11648/j.jgo.20221002.20
DO - 10.11648/j.jgo.20221002.20
T2 - Journal of Gynecology and Obstetrics
JF - Journal of Gynecology and Obstetrics
JO - Journal of Gynecology and Obstetrics
SP - 126
EP - 130
PB - Science Publishing Group
SN - 2376-7820
UR - https://doi.org/10.11648/j.jgo.20221002.20
AB - Preeclampsia is a serious obstetric situation, responsible for high maternal and perinatal morbidity and mortality. Its diagnosis is clinical and biological, with confirmation either by proteinuria on the urine dipstick or by 24-hour proteinuria constituting the gold standard. Current revisions to the definition of preeclampsia tend to free themselves from reliance on proteinuria for diagnosis. They are oriented towards a broader model where the involvement of a target organ concomitant with gestational hypertension is sufficient to make the diagnosis of preeclampsia. Late positivity of proteinuria after the onset of arterial hypertension (HTA) has been reported, contrasting with the precocity of angiogenic factors such as soluble Fms tyrosine kinase type 1 (sFlt-1) and placental growth factor (PlGF). Objective. To evaluate the performance of the sFLT-1/PLGF ratio in the diagnosis of preeclampsia. Methods. Cross-sectional multicenter analytical study conducted from October 17 to December 17, 2020 including hypertensive pregnant women, treated or not, with more than 20 weeks of amenorrhea. These all benefited from the Elisa assay of sFLT-1 and PlGF after carrying out the proteinuria on the urine dipstick during the consultation. Preeclampsia was defined by the double positivity of proteinuria on the urine dipstick associated with high blood pressure (Systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg). SPSS software was used for statistical analysis and calculation of performance indices (Se; Sp; PPV; NPV; Youden “J” index, AUC). The p-value of the probability was considered significant for a value Results. Pregnant women were mostly multiparous with a median age of 31 years (24-35). Preeclampsia was noted in 69.2% of cases. sFLT-1 was significantly higher in preeclamptic pregnant women (409±18.9 vs 194.6±12.9; pConclusion. The sFlt-1/PlGF ratio was effective in the diagnosis of preeclampsia.
VL - 10
IS - 2
ER -

Copy | Download

Author Information

Eouani Levy Max Emery

Obstetrics Gynecology Department, Loandjili General Hospital, Pointe Noire, Congo
Buambo Gauthier Regis Jostin

Obstetrics Gynecology Department, University Hospital Center of Brazzaville, Brazzaville, Congo
Mouhingou Belmar Nick-Desy

Laboratory, Faculty of Health Sciences, Marien Ngouabi University, Brazzaville, Congo
Mokoko Jules Cesar

Obstetrics Gynecology Department, University Hospital Center of Brazzaville, Brazzaville, Congo
Potokoue Mpia Sekangue Samantha Nuelly

Obstetrics Gynecology Department, University Hospital Center of Brazzaville, Brazzaville, Congo
Itoua Clautaire

Obstetrics Gynecology Department, University Hospital Center of Brazzaville, Brazzaville, Congo
Iloki Leon Herve

Obstetrics Gynecology Department, University Hospital Center of Brazzaville, Brazzaville, Congo

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Eouani Levy Max Emery, Buambo Gauthier Regis Jostin, Mouhingou Belmar Nick-Desy, Mokoko Jules Cesar, Potokoue Mpia Sekangue Samantha Nuelly, et al. (2022). Performance of the sFLT-1 / PLGF Ratio in the Diagnosis of Preeclampsia in Four Hospitals in Brazzaville (Republic of Congo). Journal of Gynecology and Obstetrics, 10(2), 126-130. https://doi.org/10.11648/j.jgo.20221002.20

Copy | Download

ACS Style

Eouani Levy Max Emery; Buambo Gauthier Regis Jostin; Mouhingou Belmar Nick-Desy; Mokoko Jules Cesar; Potokoue Mpia Sekangue Samantha Nuelly, et al. Performance of the sFLT-1 / PLGF Ratio in the Diagnosis of Preeclampsia in Four Hospitals in Brazzaville (Republic of Congo). J. Gynecol. Obstet. 2022, 10(2), 126-130. doi: 10.11648/j.jgo.20221002.20

Copy | Download

AMA Style

Eouani Levy Max Emery, Buambo Gauthier Regis Jostin, Mouhingou Belmar Nick-Desy, Mokoko Jules Cesar, Potokoue Mpia Sekangue Samantha Nuelly, et al. Performance of the sFLT-1 / PLGF Ratio in the Diagnosis of Preeclampsia in Four Hospitals in Brazzaville (Republic of Congo). J Gynecol Obstet. 2022;10(2):126-130. doi: 10.11648/j.jgo.20221002.20

Copy | Download

@article{10.11648/j.jgo.20221002.20,
  author = {Eouani Levy Max Emery and Buambo Gauthier Regis Jostin and Mouhingou Belmar Nick-Desy and Mokoko Jules Cesar and Potokoue Mpia Sekangue Samantha Nuelly and Itoua Clautaire and Iloki Leon Herve},
  title = {Performance of the sFLT-1 / PLGF Ratio in the Diagnosis of Preeclampsia in Four Hospitals in Brazzaville (Republic of Congo)},
  journal = {Journal of Gynecology and Obstetrics},
  volume = {10},
  number = {2},
  pages = {126-130},
  doi = {10.11648/j.jgo.20221002.20},
  url = {https://doi.org/10.11648/j.jgo.20221002.20},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.jgo.20221002.20},
  abstract = {Preeclampsia is a serious obstetric situation, responsible for high maternal and perinatal morbidity and mortality. Its diagnosis is clinical and biological, with confirmation either by proteinuria on the urine dipstick or by 24-hour proteinuria constituting the gold standard. Current revisions to the definition of preeclampsia tend to free themselves from reliance on proteinuria for diagnosis. They are oriented towards a broader model where the involvement of a target organ concomitant with gestational hypertension is sufficient to make the diagnosis of preeclampsia. Late positivity of proteinuria after the onset of arterial hypertension (HTA) has been reported, contrasting with the precocity of angiogenic factors such as soluble Fms tyrosine kinase type 1 (sFlt-1) and placental growth factor (PlGF). Objective. To evaluate the performance of the sFLT-1/PLGF ratio in the diagnosis of preeclampsia. Methods. Cross-sectional multicenter analytical study conducted from October 17 to December 17, 2020 including hypertensive pregnant women, treated or not, with more than 20 weeks of amenorrhea. These all benefited from the Elisa assay of sFLT-1 and PlGF after carrying out the proteinuria on the urine dipstick during the consultation. Preeclampsia was defined by the double positivity of proteinuria on the urine dipstick associated with high blood pressure (Systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg). SPSS software was used for statistical analysis and calculation of performance indices (Se; Sp; PPV; NPV; Youden “J” index, AUC). The p-value of the probability was considered significant for a value Results. Pregnant women were mostly multiparous with a median age of 31 years (24-35). Preeclampsia was noted in 69.2% of cases. sFLT-1 was significantly higher in preeclamptic pregnant women (409±18.9 vs 194.6±12.9; pConclusion. The sFlt-1/PlGF ratio was effective in the diagnosis of preeclampsia.},
 year = {2022}
}

Copy | Download